Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parikh

Showing results (191-200 of 399) with videos related to

Pageof 40
Sort By:
Journal of Neuroengineering and Rehabilitation|November 18, 2009
The New Jersey Institute of Technology Robot-Assisted Virtual Rehabilitation (NJIT-RAVR) system for children with cerebral palsy: a feasibility studyQinyin Qiu, Diego A Ramirez, Soha Saleh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 18, 2023
ReplyAmit G Singal, Darine Daher, Karim Seif El Dahan, et al.
The American Journal of Gastroenterology|March 14, 2018
Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic TestsElliot B Tapper, Neehar D Parikh, Akbar K Waljee, et al.
Journal of Hepatocellular Carcinoma|February 12, 2025
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United StatesRichard S Finn, Renuka Iyer, Richard S Kalman, et al.
Digestive Diseases and Sciences|October 21, 2021
Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive ComplicationsDaniel A Burkholder, Isabel J Moran, Jacob V DiBattista, et al.
BMC Cancer|January 19, 2023
Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference studyNeehar D Parikh, Allicia Girvan, Joshua Coulter, et al.
Hepatology (Baltimore, Md.)|May 8, 2019
The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice ProvidersElliot B Tapper, Shengchen Hao, Menghan Lin, et al.
The American Journal of Gastroenterology|August 11, 2020
Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With CirrhosisElliot B Tapper, Lilli Zhao, Samantha Nikirk, et al.
Hepatology (Baltimore, Md.)|October 23, 2016
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare databaseNeehar D Parikh, Vincent D Marshall, Amit G Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2020
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With CirrhosisAmit G Singal, Sruthi Patibandla, Joseph Obi, et al.
Pageof 40

Showing results (191-200 of 399) with videos related to

Sort By:
Pageof 40
Journal of Neuroengineering and Rehabilitation|November 18, 2009
The New Jersey Institute of Technology Robot-Assisted Virtual Rehabilitation (NJIT-RAVR) system for children with cerebral palsy: a feasibility studyQinyin Qiu, Diego A Ramirez, Soha Saleh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 18, 2023
ReplyAmit G Singal, Darine Daher, Karim Seif El Dahan, et al.
The American Journal of Gastroenterology|March 14, 2018
Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic TestsElliot B Tapper, Neehar D Parikh, Akbar K Waljee, et al.
Journal of Hepatocellular Carcinoma|February 12, 2025
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United StatesRichard S Finn, Renuka Iyer, Richard S Kalman, et al.
Digestive Diseases and Sciences|October 21, 2021
Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive ComplicationsDaniel A Burkholder, Isabel J Moran, Jacob V DiBattista, et al.
BMC Cancer|January 19, 2023
Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference studyNeehar D Parikh, Allicia Girvan, Joshua Coulter, et al.
Hepatology (Baltimore, Md.)|May 8, 2019
The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice ProvidersElliot B Tapper, Shengchen Hao, Menghan Lin, et al.
The American Journal of Gastroenterology|August 11, 2020
Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With CirrhosisElliot B Tapper, Lilli Zhao, Samantha Nikirk, et al.
Hepatology (Baltimore, Md.)|October 23, 2016
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare databaseNeehar D Parikh, Vincent D Marshall, Amit G Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2020
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With CirrhosisAmit G Singal, Sruthi Patibandla, Joseph Obi, et al.
Pageof 40